Medicare Formulary Coverage and Restrictions for Opioid Potentiators From 2013 to 2017

Journal of General Internal Medicine - Germany
doi 10.1007/s11606-018-4752-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Use of Opioid Agonist Therapy for Medicare Patients in 2013

JAMA Psychiatry
MedicinePsychiatryMental Health
2016English

Medicare and National Coverage

Health Affairs
MedicineHealth Policy
2005English

Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018

JAMA - Journal of the American Medical Association
Medicine
2019English

A Framework to Guide the Optimal Development and Use of Real-World Evidence for Drug Coverage and Formulary Decisions

Journal of Comparative Effectiveness Research
Health Policy
2018English

Is Expanding Medicare Coverage Cost-Effective?

BMC Health Services Research
Health Policy
2005English

Declines in Physician Acceptance of Medicare and Private Coverage

Archives of Internal Medicine
2011English

Prescription Drug Coverage and Medicare Spending Among U.S. Elderly

Geneva Papers on Risk and Insurance: Issues and Practice
ManagementFinanceBusinessEconomicsAccountingEconometrics
2010English

Don't Use Your Life's Savings to Fill the Holes in Medicare Coverage!

Chemical and Engineering News
Chemical Engineering
2012English

Performance of the Centers for Medicare & Medicaid Services’ Opioid Overutilization Criteria for Classifying Opioid Use Disorder or Overdose

JAMA - Journal of the American Medical Association
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy